Epsilon Carbon Private Limited
Epsilon Carbon Private Limited
Epsilon Carbon Private Limited
Ratings
Amount (Rs.
Facilities/Instruments Rating1 Rating Action
crore)
Reaffirmed at CARE A-; Stable / CARE A2
Long Term / Short Term Bank
- - (Single A Minus; Outlook: Stable / A Two); Outlook revised
Facilities
from Negative and Withdrawn
Reaffirmed at CARE A-; Stable
Long Term Bank Facilities - - (Single A Minus; Outlook: Stable); Outlook revised from
Negative and Withdrawn
0.00
Total Bank Facilities
(Rs. Only)
Details of facilities in Annexure-1
1
Complete definition of the ratings assigned are available at www.careedge.in and other CARE Ratings Ltd.’s publications
with JSWSL coupled with proximity to the source of raw material, ensures assured raw material availability on a sustained basis.
With secured supply of crude coal tar, the production of carbon black will not be dependent on procurement from external
sources.
Supply contract for products with aluminium and graphite producers
ECPL enters into supply contracts (for a year) with various companies including Vedanta Limited, Hindalco Industries Limited,
Colourtex Industries Pvt. Ltd, Bharat Aluminium Company Limited, Continental Carbon India Ltd, LRC Specialty Chemicals
Private Limited, Mangalore Chemicals & Fertilizers Ltd etc for the supply of CTP and other various products. The prices of CTP
are passed on its customer with index+ conversion cost. Thus, the contracts fix the product volume off-take as well as
conversion price of the company giving reasonable revenue visibility during the tenure of contracts. The prices are passed on to
customer on fortnightly basis which is based on the index pricing.
Healthy operating margins
The PBILDT margin of the company have improved to 19.72% in FY21 as compared to 14.23% in FY20. Increased focus on the
sale of manufactured goods and by-product sales leading to improvement in the PBILDT margins y-o-y. During 11MFY22 (UA)
ECPL achieved turnover of Rs.1580crore and reported PBILDT of Rs.265crore, backed by a better CTP capacity utilization,
improved realizations and healthy demand from key end user industries. ECPL also benefits from declining coal tar production in
China amid plant shutdowns, which has constrained Chinese supply of CTP and CB. Gradual ramp-up in CB sales is expected in
the near term.
Moderate Capital structure
The capital structure moderated over the past two years on account of debt-funded capex of over Rs 450 crore. ECPL set up a
new CB facility of 115,000-TPA capacity. ECPL also set up a 2,500-TPA capacity in its subsidiary, EAMPL, for advance carbon
materials to be used in rechargeable batteries. This debt-funded capex has led to moderation in gearing to 1.66 times as on
March 31, 2021, from 0.92 time as on March 31, 2019. ECPL’s reliance on short-term working capital debt remains limited, as it
is supported by procurement credit available from suppliers. Interest coverage ratio stood at 8.27 times in FY21 on account of
healthy operating profitability.
Liquidity: Adequate
The liquidity of ECPL remains adequate, due to healthy cash accrual and moderately utilised bank limits. Bank limit utilization
averaged 70% over the 12 months ending December 2021. Also, it maintains surplus liquidity of around Rs.15crore of
cash/bank balance to meet any exigencies.
Applicable Criteria
Criteria on assigning Outlook to Credit Ratings
CARE’s Policy on Default Recognition
Criteria for Short Term Instruments
Rating Methodology-Manufacturing Companies
Financial ratios - Non-Financial Sector
Rating Methodology: Consolidation
Liquidity Analysis- Non-Financial Sector
Criteria for Rating Credit Enhanced Debt
Note on complexity levels of the rated instrument: CARE has classified instruments rated by it on the basis of complexity.
Investors/market intermediaries/regulators or others are welcome to write to care@careedge.in for any clarifications.
Contact us
Media Contact
Name: Mradul Mishra
Contact no.: +91-22-6754 3573
Email ID: mradul.mishra@careedge.in
Analyst Contact
Name: Arunava Paul
Contact no.: +91-22-6754 3667
Email ID: arunava.paul@careedge.in
Relationship Contact
Name: Saikat Roy
Contact no.: +91-98209 98779
Email ID: saikat.roy@careedge.in
CARE’s ratings are opinions on the likelihood of timely payment of the obligations under the rated instrument and are not recommendations to sanction, renew,
disburse or recall the concerned bank facilities or to buy, sell or hold any security. CARE’s ratings do not convey suitability or price for the investor. CARE’s ratings
do not constitute an audit on the rated entity. CARE has based its ratings/outlooks on information obtained from sources believed by it to be accurate and reliable.
CARE does not, however, guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results
obtained from the use of such information. Most entities whose bank facilities/instruments are rated by CARE have paid a credit rating fee, based on the amount
and type of bank facilities/instruments. CARE or its subsidiaries/associates may also have other commercial transactions with the entity. In case of
partnership/proprietary concerns, the rating /outlook assigned by CARE is, inter-alia, based on the capital deployed by the partners/proprietor and the financial
strength of the firm at present. The rating/outlook may undergo change in case of withdrawal of capital or the unsecured loans brought in by the
partners/proprietor in addition to the financial performance and other relevant factors. CARE is not responsible for any errors and states that it has no financial
liability whatsoever to the users of CARE’s rating. Our ratings do not factor in any rating related trigger clauses as per the terms of the facility/instrument, which
may involve acceleration of payments in case of rating downgrades. However, if any such clauses are introduced and if triggered, the ratings may see volatility and
sharp downgrades.
**For detailed Rationale Report and subscription information, please contact us at www.careedge.in